TPO-R | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

25,279 results for “TPO-R”

Trials

View all 8883 →

Active, not recruiting

Eltrombopag for Moderate Aplastic Anemia

34 participants · First posted Apr 4, 2011

A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

43 participants · First posted Jun 17, 2009

A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)

30 participants · First posted Aug 18, 2009

Drugs

View all 1422 →

TPO-7640

rh-TPO

RI-TPO

Organizations

View all 344 →

R&R, Inc.

United States

Anabio R&D

Vietnam

R-Biopharm AG

Germany

News

View all 14630 →

Handok Gains Korean Approval for Doptelet to Treat ITP and CLD-Related Thrombocytopenia

TAVALISSE® (Fostamatinib) Approved in Mexico for Chronic ITP Treatment

Mission Bio's Single-Cell Platform Advances Biomarker Analysis for Incyte's MPN Therapy at ASH 2025

Page 1 of 2528